Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Antisense Oligonucleotides. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107556355B discloses a novel synthesis route for high-purity nucleoside diphosphite amides, enabling superior quality control in antisense drug manufacturing.
Novel cesium carbonate catalyzed process for high-purity nucleoside modifiers. Reduces cost and improves supply chain reliability for antisense drug manufacturing.
Novel synthesis patent CN109053839A enables high-purity nucleoside modifiers. Significant cost reduction and scalable supply chain for antisense drug manufacturing.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.